Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patients

Cancer Science

Volumn 101, Issue 9, 2010, Pages 2074-2079

  Tamaki K , Kentaro ^a,b,c   Sasano, Hironobu ^b   Ishida, Takanori ^a   Miyashita, Minoru ^a   Takeda, Motohiro ^a   Amari, Masakazu ^a   Tamaki, Nobumitsu ^c   Ohuchi, Noriaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c Nahanishi Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SENSITIVITY AND SPECIFICITY;

EID: 77956030566     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01630.x     Document Type: Article

References (29)

1. Sutela A, Vanninen R, Sudah M. Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer. Acta Oncol 2008, 47:38-46.
2. Arnedos M, Nerurkar A, Osin P. Discodance between core needle biopsy (CNB) and excision biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC). Ann Oncol 2009, 20:1948-52.
3. Pettine S, Place R, Babu S. Stereotactic breast biopsy is accurate, minimally invasive, and cost effective. Am J Surg 1996, 171:474-6.
4. Britton PD. Fine needle aspiration or core biopsy. The Breast 1999, 8:1-4.
5. Usami S, Moriya T, Amari M. Reliability of prognostic factors in breast carcinoma determined by core needle biopsy. Jpn J Clin Oncol 2007, 37:250-5.
6. Cavaliere A, Sidoni A, Scheibel M. Biopathologic profile of breast cancer core biopsy: is it always a valid method? Cancer Lett 2005, 14:22-7.
7. Park SY, Kim KS, Lee TG. The accuracy of preoperative core biopsy in determining histologic grade, hormone receptors, and human epidermal growth factor receptor 2 status in invasive breast cancer. Am J Surg 2009, 197:266-9.
8. Dronkers DJ. Stereotaxic core biopsy of breast lesions. Radiology 1992, 183:631-4.
9. Brenner RJ, Fajardo L, Fisher PR. Percutaneous core biopsy of the breast: effect of operator experience and number of samples on diagnostic accuracy. Am J Roentgenol 1996, 166:341-6.
10. Tavassoli FA, Devilee P. World health organization classification of tumors. Tumor of the breast and females gentia organs 2003, Lyon, IARC Press
11. Rosen PP. Rosen's Breast Pathology 2009, 3rd edn, Philadelphia, PA, USA, Lippincott Williams & Wilkins
12. Tsuda H, Akiyama F, Kurosumi M. Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) pathology section. Jpn J Clin Oncol 1998, 28:486-91.
13. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998, 11:155-68.
14. Arihiro K, Umemura S, Kurosumi M. Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays. Am J Clin Pathol 2007, 127:356-65.
15. Goldhirsch A, Ingle JN, Gelber RD. Threshholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 2009, 20:1319-29.
16. Kurosumi M. Immunohistochemical assessment of hormone receptor status using a new scoring system (J-score) in breast cancer. Breast Cancer 2007, 14:189-93.
17. Chivukula M, Bhargava R, Brufsky A. Clinical importance of HER2 immunohistologic heterogenous expression in core-needle biopsies vs resection specimens for equivocal (immunohistochemical score 2+) cases. Mod Pathol 2008, 21:363-8.
18. Fleiss JL. Statistical Methods for Rates and Proportions 1981, 212-36. New York, John Wiley & Sons
19. Shannon J, Douglas-Jones AG, Dallimore NS. Conversion to core biopsy in preoperative diagnosis of breast lesions. Is it justified by the results? J Clin Pathol 2001, 54:762-5.
20. Frank SL, Frank JL, March D. Does therapeutic touch ease the discomfort or distress of patients undergoing stereotactic core breast biopsy? A randomized clinical trial. Pain Med 2007, 8:419-24.
21. Somerville P, Seifert P, Destounis SV. Anticoagulation and bleeding risk after core needle biopsy. AJR Am J Roentgenol 2008, 191:1194-7.
22. Witt A, Yavuz D, Walchetseder C. Preoperative core needle biopsy as an independent risk factor for wound infection after breast surgery. Obstet Gynecol 2003, 101:745-50.
23. Liberman L, Vuolo M, Dershaw DD. Epithelial displacement after stereotactic 11-gauge directional vacuum-assisted breast biopsy. AJR Am J Roentgenol 1999, 172:677-81.
24. Buzdar AU, Ibrahim NK, Francis D. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol 2005, 23:3676-85.
25. Baselga J, Semiglazov V, Manikhas GM. Efficacy of neoadjuvant trastuzumab in patients with inflammatory breast cancer: data from the noah (Neoadjuvant Herceptin) phase iii trial [abstract 2030]. Eur J Cancer 2007, 5:193.
26. Dagrada GP, Mezzelani A, Alasio L. HER-2/neu assessment in primary chemotherapy treated breast carcinoma: no evidence of gene profile changing. Breast Cancer Res Treat 2003, 80:207-14.
27. Fishman JE, Milikowski C, Ramsinghani R. US-guided core-needle biopsy of the breast: how many specimens are necessary? Radiology 2003, 226:779-82.
28. Kaplan SS, Racenstein MJ, Wong WS. US-guided core biopsy of the breast with a coaxial system. Radiology 1995, 194:573-5.
29. Melotti MK, Berg WA. Core needle breast biopsy in patients undergoing anticoagulation therapy: preliminary results. AJR Am J Roentgenol 2001, 174:245-9.